ANTIBODY COMPOSITIONS
The present invention relates to a (bio) pharmaceutical composition, in particular to a liquid (e.g., aqueous) biopharmaceutical composition, and more particularly to a liquid biopharmaceutical composition comprising an anti-EGFR/anti-LGR5 bispecific antibody. The invention also relates to a method...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
22.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a (bio) pharmaceutical composition, in particular to a liquid (e.g., aqueous) biopharmaceutical composition, and more particularly to a liquid biopharmaceutical composition comprising an anti-EGFR/anti-LGR5 bispecific antibody. The invention also relates to a method of making the composition; a kit comprising the composition; a package comprising the composition; a method of manufacturing the package; and therapeutic methods of using the compositions and/or packages, particularly for cancer treatment, such as for the treatment of colorectal cancer.
本发明涉及一种(生物)医药组合物,尤其涉及一种液体(例如水性)生物医药组合物,更尤其涉及一种包含抗EGFR/抗LGR5双特异性抗体的液体生物医药组合物。本发明还涉及一种制造该组合物的方法;一种包括该组合物的试剂盒;一种包括该组合物的包装;一种制造该包装的方法;及使用该组合物及/或包装尤其进行癌症治疗,例如用于治疗结肠直肠癌的治疗方法。 |
---|---|
Bibliography: | Application Number: CN202180092920 |